Evidence map›Paper›PMID 37407877›Full record

ArticlePharmaceutical research2023

Enabling Efficient Design of Biological Formulations through Advanced Characterizations.

Kang Chen, Jason K Cheung, Hai-Young Anne Kim, Anthony Leone, Krishna Mallela, Yongchao Su

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. mAbs
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kang ChenDivision of Complex Drug Analysis, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA.
Jason K CheungBiologics Analytical Research and Development, Analytical Research and Development, Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Hai-Young Anne KimAnalytical Research and Development, BioTherapeutics Pharmaceutical Sciences, Pfizer, Inc., Andover, MA, 01810, USA.
Anthony LeoneAnalytical Development and Attribute Sciences, Bristol Myers Squibb, New Brunswick, NJ, 08901, USA.
Krishna MallelaCenter for Pharmaceutical Biotechnology, Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Yongchao SuAnalytical Enabling Capabilities, Analytical Research and Development, Merck & Co., Inc., Rahway, NJ, 07065, USA. yongchao.su@merck.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chemistry, PharmaceuticalDrug Compounding

Identifiers

PMID37407877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.